Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Labcyte and Deerac Fluidics Combine Forces to Enhance Low Volume Liquid Handling

Published: Wednesday, January 30, 2008
Last Updated: Wednesday, January 30, 2008
Bookmark and Share
Labcyte and Allegro Technologies Limited have reached agreement on the terms for combination of the two companies.

Labcyte Inc. and Allegro Technologies Limited, which conducts business as Deerac Fluidics, announced that they have reached agreement on the terms for combination of the two companies. Completion of the transaction requires shareholder approval and is expected within one month.

As pharmaceutical companies, genomic service providers, and other life science research organizations desire to perform larger numbers of assays within fixed budgets, there is a strong drive to reduce the volume of each assay in order to reduce cost and minimize waste.

According to both companies, although products from both Labcyte and Deerac address the growing market of low-volume liquid handling, each company utilizes a unique technology and they operate in different volume ranges. Products from Labcyte and Deerac are used for different applications. They may also be used together when one component of an assay is added in the low nanoliter range and others are added in larger amounts.

The Deerac products are based on a patented feed-back controlled system which effective in the 50 nanoliter to 20 microliter range. This technology was conceived at Trinity College Dublin, and its development was supported by grants from Enterprise Ireland.

The Labcyte Echo ® liquid handlers use acoustic energy to transfer 2.5 nanoliter droplets and are most useful in the 2.5 to 200 nanoliter range.

“At Labcyte, we evaluated a wide variety of low-volume liquid handlers and found the Deerac Latitude™ and Equator™ to have the best precision in the 50 nanoliter range. We also found that the speed and flexibility of the Latitude could double the throughput of our new POD™ 810 plate assembler for assay plate preparation. The two teams have also conducted several joint seminars on low-volume assays and our people work well together,” said Dr. Elaine J. Heron, Chief Executive Officer of Labcyte. “It became clear that it made sense to combine the two companies.”

“Having research and manufacturing groups in Dublin gives us a solid base from which to support our growing business in Europe,” continued Dr. Heron. “Dublin offers a vibrant research community with business-friendly policies. The innovative atmosphere created by Trinity College Dublin makes location of our European operations close by especially attractive.”

“We are excited to become part of the business that has brought acoustic droplet ejection from a concept to a mainstream product used by most pharmaceutical companies,” said Dr. Jurgen Osing, the Managing Director of Deerac Fluidics, “and we are anxious to use our expertise in genomics to expand the applications of Labcyte Echo systems. This is also an opportunity for providing more local support for the Latitude and Equator products.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!